| 查看: 806 | 回复: 4 | |||
| 【奖励】 本帖被评价3次，作者喜鹊喜鹊增加金币 2.2 个 | |||
[资源]
药物代谢组学案例分析
|
|||
|
药理研究：奥曲肽的肝脏保护作用 研究对象：大鼠 分析检测平台：GC-TOF／MS（BIOTREE） 期刊：Liver international 影响因子：4.85 发表时间：2015 摘要： Background & Aims: Insufficient liver regeneration and hepatocyte injury caused by excessive portal perfusion are considered to be responsible for post-hepatectomy liver failure (PLF) or small-for-size syndrome in living- donor liver transplantation. Somatostatin can decrease portal vein pressure (PVP) but simultaneously inhibits liver regeneration. This interesting para- dox motivated us to investigate the outcome of PLF in response to somatostatin treatment. Methods: Rats receiving extended partial hepatectomy (90% PH) were treated with octreotide, a somatostatin analogue, or placebo. Animal survival, serum parameters and hepatic histology were evaluated. Metabolomic analysis was performed to investigate the effect of octreotide on hepatocyte metabolism. Results: Despite significantly inhibiting early regeneration, octreotide application noticeably improved the hepatic histology, liver function and survival after PH but did not decrease the PVP level. Metabolomic analysis exhibited that octreotide profoundly and exclusively altered the levels of five metabolites that participate in or closely associate with the methionine cycle, a biochemical reaction that uniquely produces S-adenosylmethionine (SAMe), an active methyl residual donor for methyl- transferase reactions. Among these metabolites, methylthioadenosine (MTA), a derivate of SAMe, increased three-fold and was found independently improve the hepatic histology and reduce inflammatory cytokines in hepatectomized rats. Conclusions: Octreotide exclusively regulates the methionine cycle reaction and augments the MTA level in hepatocytes. MTA prominently protects hepatocytes against shear stress injury and reduces the secondary inflammation, thereby protecting rats from PLF. Keywords: hepatectomy liver failure (PLF)、portal vein pressure (PVP)、methylthioadenosine (MTA) 研究背景： 肝脏在部分切除后仍可通过激活成熟肝细胞进行自我修复，这一特点是肝脏切除术及肝脏活体移植（living-donor liver transplantation， LDLT）技术的重要基础。然而在治疗复杂肝脏疾病时，采用肝脏切除术后常发现术后肝功能失常（post-hepatectomy liver failure, PLF），且肝脏移植后常出现小体积综合症（small-for-size syndrome, SFSS），导致术后死亡率升高。 门静脉过度灌注是PLF的重要征兆，同时门静脉血压和剪切力升高也可直接导致SFSS。因此降低门静脉血压可作为预防SFSS和PLF的一种有效策略。奥曲肽是一种生长抑素，具有降低PVP作用，临床常用于治疗肝硬化引起的上消化道出血。虽然有报道称奥曲肽可降低SFSS发生率，但其机制尚不明确。同时，作为生长抑素，该药品是否会因抑制肝脏细胞再生而导致PLF尚不确定。为尝试回答这些问题，本文尝试在大鼠肝切除术模型中研究奥曲肽的作用效果和机制。 |
回复此楼» 本帖附件资源列表
-
欢迎监督和反馈：小木虫仅提供交流平台，不对该内容负责。
本内容由用户自主发布，如果其内容涉及到知识产权问题，其责任在于用户本人，如对版权有异议，请联系邮箱：xiaomuchong@tal.com - 附件 1 : 代谢组学-药物代谢组学-案例分析-316.pdf
2017-04-01 11:54:56, 514.62 K
» 猜你喜欢
国际普刊官网征稿INVESTIGATION OF LIFE SCIENCE
已经有8人回复
-
200一版的国际普刊（新刊活动），全流程只需七天
已经有2人回复
-
植物学论文润色/翻译怎么收费?
已经有140人回复
-
适合大创赛生科赛结项，学分紧急的同学，国际新刊INVESTIGATION OF LIFE SCIENCE
已经有18人回复
-
INVESTIGATION OF LIFE SCIENCE 第三期开放投稿，审稿快、版面费低
已经有18人回复
-
新审查指南施行半年，AI方向的专利申请是不是更看"技术味"了？
已经有22人回复
-
专利优先审查新办法出了，哪些成果值得走快速预审通道？
已经有33人回复
-
新审查指南堵死了"一案双申"的老路，实用新型和发明只能二选一了？
已经有27人回复
-
课题快结题了才发现没东西可申请专利？四个维度帮你挖一挖
已经有22人回复
-
论文投出去之前到底要不要先申请专利？被审稿周期坑过一次后的复盘
已经有8人回复
4楼2018-06-12 09:17:21
简单回复
capacha2楼
2017-09-29 15:03
回复
五星好评 顶一下，感谢分享！
2018-02-20 15:52
回复
五星好评 顶一下，感谢分享！
2019-12-19 10:04
回复
三星好评 顶一下，感谢分享！
30